Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Elanco Animal Health
AddedMar 19, 2024
UpdatedJun 28, 2026
Elanco Animal Health

Elanco Animal Health

Public

Global animal health company in Greenfield, IN, developing products for pets and livestock.

HQ
Greenfield, IN, US
Founded
2018
Overview
Compare
Fundraising
Employees

Founded in 1954 and headquartered in Greenfield, Indiana, Elanco Animal Health is a global leader in the animal pharmaceutical industry. The company’s core mission is to enhance the health and well-being of animals, both companion and livestock, through innovative products. Elanco develops, manufactures, and markets a range of pharmaceutical drugs aimed at improving animal health and productivity. Serving clients worldwide, Elanco focuses on providing solutions that support both pet owners and food producers.

Notable figures affiliated with Elanco include Chairman R. David Hoover and CEO Jeff Simmons. The company is publicly traded on the NYSE under the ticker ELAN and is a component of the Russell 1000 index. In 2021, Elanco reported revenues of $4.765 billion. Despite facing financial challenges with a net income loss of $0.472 billion in the same year, Elanco continues to make significant strides in the animal health sector, impacting global animal care practices and contributing to the overall well-being of animals around the world.

Elanco Animal Health - Quick Facts

When was Elanco Animal Health founded?

Elanco Animal Health was founded in 2018.

Where is Elanco Animal Health's headquarters located?

Elanco Animal Health's headquarters is located in Greenfield, IN, US.

How much has Elanco Animal Health raised to-date?

As of Sep 19, 2018, Elanco Animal Health has raised a total of $2.9M (USD).

How many employees does Elanco Animal Health have?

Elanco Animal Health has 1,080 employees as of Feb 6, 2024.

Elanco Animal Health - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • AgTech
Unique IDs
  • secCik: 0001739104
  • ticker: ELAN
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424900Miscellaneous Nondurable Goods Merchant Wholesalers
  • 424910Farm Supplies Merchant Wholesalers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 5100Wholesale trade--nondurable goods
  • 5190Miscellaneous Nondurable Goods
  • 5191Farm Supplies
  • 4000Railroad Transportation
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research